tofacitinib (Aclaris Therapeutics)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nametofacitinib (Aclaris Therapeutics)
Drug Alias NameJAK Inhibitor (Aclaris Therapeutics)tofacitinib
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionJanus kinase inhibitors
TargetsJanus kinase
Therapy Area/IndicationsAlopecia AreataAlopecia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesConfluence Life Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesConfluence Life Sciences IncAclaris Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAlopecia AreataAlopecia

Other Information

ATC CodeN/A
Related LinksN/A